Joshua Zelig

Joshua Zelig is a Director at Biomark Capital, a position he has held since November 2013.12 With a background in finance and healthcare venture capital, Zelig brings significant experience to his role at Biomark Capital.

Career History

Prior Positions:: Before joining Biomark Capital, Zelig served as a Director at Burrill & Company from January 2012 to November 2013.2 He also held the position of Associate Partner at GBP Capital, a Greenwich, Connecticut-based healthcare venture firm.1

Early Career:: Zelig's career began in equity research at Morgan Stanley, where he worked as an associate covering biotech and consumer stocks. Following this, he gained experience in real estate management, acquisition, and due diligence, working with large private real estate companies and public REITs.1

Responsibilities at Biomark Capital

As a Director at Biomark Capital, Zelig is likely involved in:

1. Sourcing, evaluating, and executing investment transactions
2. Managing intellectual property portfolios
3. Overseeing company operations
4. Working closely with portfolio companies to set and deliver strategic objectives1

Education

Zelig graduated from Yeshiva University's Sy Syms School of Business with a Bachelor of Science in Finance.1

Skills and Expertise

Given his background and current role, Zelig likely possesses expertise in:

• Healthcare and biotechnology investments
• Venture capital
• Financial analysis
• Strategic planning
• Intellectual property management

Joshua Zelig's diverse experience in finance, healthcare, and venture capital positions him as a valuable asset in his role as Director at Biomark Capital.